Evidence map›Paper›PMID 38985230›Full record

ArticleJournal of patient-reported outcomes2024

Demonstrating the benefit of a cellulitis-specific patient reported outcome measure (CELLUPROM

Marie Gabe-Walters, Melanie Thomas, Linda Jenkins

Abstract read
In one paragraph

Article in Journal of patient-reported outcomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marie Gabe-WaltersLymphoedema Wales Clinical Network, Swansea Bay University Health Board, Swansea, Wales. marie.gabe-walters@wales.nhs.uk.ORCID 0000-0002-0384-7149
Melanie ThomasLymphoedema Wales Clinical Network, Swansea Bay University Health Board, Swansea, Wales.
Linda JenkinsNational Cellulitis Improvement Programme Lead, Lymphoedema Wales Clinical Network, Swansea Bay University Health Board, Swansea, Wales.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDespite a known risk of cellulitis recurrence, the management of the wider impact and risk factors has been neglected. The innovative National Cellulitis Improvement Programme (NCIP) addresses this by providing evidence-based and individualised care to improve patient reported outcomes and reduce the risk of recurrence. The aim of this paper is to examine the longer-term impact of cellulitis and to identify a suitable and clinically relevant Patient Reported Outcome Measure (PROM).

methodsA review of existing cellulitis-specific PROMs was undertaken, alongside literature detailing the patient-focused impact of cellulitis, to identify a suitable PROM for clinical use. A group of expert therapists and patient representatives (n = 14) shared their individual and collective experiences over a series of events to discuss and debate the impact of cellulitis and review available PROMs. CELLUPROM

resultsNo cellulitis-specific PROMs were identified. Literature focused on the signs and symptoms of an acute episode of cellulitis, with outcome measures primarily used to evidence the impact of an intervention. An enduring physical, social and emotional impact of cellulitis was identified in this study, providing the basis for the new cellulitis-specific PROM (CELLUPROM

conclusionThis study has highlighted the lasting impact of cellulitis. Using CELLUPROM

Indexed as

CellulitisPatient Reported Outcome MeasuresAdultAgedFemaleHumansMaleMiddle AgedQuality of LifeRecurrenceWalesCellulitisErysipelasPatient reported outcome measuresValue-based healthcare

Identifiers

PMID38985230
PMCPMC11236826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.